首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1414447

2024 年神經調節全球市場報告

Neuromodulation Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，神經調節的市場規模迅速擴大。將從2023年的64.3億美元成長到2024年的71.4億美元，複合年成長率為11.1%。神經調節場的表現很大程度取決於幾個因素。慢性病的盛行率不斷上升，支持神經調節治療的臨床證據和研究不斷積累，患者對非侵入性治療方案的需求不斷成長，以及支持這些進展的政府舉措和資金；這些包括擴大這些治療方法的適應症，以及領域內的合作和夥伴關係促進創新和發展的產業。

神經調節市場規模預計在未來幾年將快速成長。 2028年將以10.5%的年複合成長率（CAGR）成長至106.4億美元。許多因素與預期的成長有關，特別是設備的小型化、對老齡化人口中普遍存在的神經系統疾病的日益關注、精神病學應用的增加、以患者為中心的治療方法以及健康方面的例子包括擴大全球護理的覆蓋範圍。

神經系統疾病的盛行率不斷上升是推動神經調節市場成長的關鍵因素。這些疾病包括影響大腦、神經和脊髓的各種問題。神經調節干預措施為管理和調節各種神經系統疾病（包括阿茲海默症、帕金森氏症和癲癇）提供了一條有前途的途徑。歐洲腦理事會2022年4月舉行的報告報告稱，全球整體有600多種神經系統疾病和近300種精神疾病，其中包括阿茲海默症和其他失智症，人數已達5,000萬人。癲癇症影響全球 6500 萬人，凸顯了神經系統疾病的重大影響。預計到 2050 年，歐洲失智症患者人數將從 1,050 萬大幅增加至 1,870 萬，這使得神經調節對於解決這些日益嚴重的健康問題至關重要。事實表明，它發揮了作用。

醫療保健支出的增加將推動神經調節市場的成長。醫療保健支出包括各種與健康相關的活動的支出，例如服務、保險、研究和公共衛生舉措。醫療保健支出的增加推動了神經系統疾病創新治療方法和診斷的進步和採用。強大的財政資源也支持對新技術的廣泛研究，以提高其有效性、安全性和準確性。值得注意的是，英國國家統計局報告稱，從 2020 年到 2021 年，英國醫療保健支出名目增加 9.4%，實際成長 9.7%。此外，2021年預防性醫療保健支出激增至457.2億美元，比前一年成長了一倍多，這表明對神經調節市場的成長做出了重大貢獻。

2023 年神經調節市場最大的地區是北美。神經調節市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

全球神經調節市場，依技術細分、實際和預測，2018-2023、2023-2028、2033
內部神經調節
體外神經調節（非侵入性）
全球神經調節市場，依生物材料細分，實際與預測，2018-2023、2023-2028、2033
高分子生物材料
金屬生物材料
陶瓷生物材料
全球神經調節市場，依應用、實際及預測細分，2018-2023、2023-2028、2033
慢性疼痛
尿失禁和大便失禁
偏頭痛
故障恢復綜合症
帕金森氏症
癲癇
發抖
憂鬱症
其他用途
全球神經調節市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
醫院
診所
家庭保健

第 7 章區域與國家分析

全球神經調節市場，按地區、實際和預測，2018-2023、2023-2028、2033
全球神經調節市場，按國家、實際和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

神經調節市場的競爭形勢
神經調節市場公司概況
- Abbott Laboratories
- Soterix Medical Inc.
- Boston Scientific Corporation
- Medtronic plc
- Synapse Biomedical Inc.

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章重大併購

第34章未來前景與可能性分析

第35章附錄

簡介目錄

Product Code: r11957

“Neuromodulation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuromodulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuromodulation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The neuromodulation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Technology: Internal Neuromodulation; External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial; Metallic Biomaterial; Ceramic Biomaterial
3) By Application: Chronic Pain; Urinary And Fecal Incontinence; Migraine; Failed Back Syndrome; Parkinson Disease; Epilepsy; Tremor; Depression; Other Applications
4) By End-User: Hospitals; Clinics; Home Healthcare
Companies Mentioned: Abbott Laboratories; Soterix Medical Inc.; Boston Scientific Corporation; Medtronic plc; Synapse Biomedical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Neuromodulation refers to the adjustment of nerve activity through electrical or pharmacological means, directly targeting specific areas. It's a reversible method employed to alleviate pain.

The primary technologies in neuromodulation include internal and external methods. Internal neuromodulation involves implanting an electrode near a targeted nerve and administering a low-voltage electric current. Biomaterials used encompass polymeric, metallic, and ceramic materials. These technologies are applied in treating various conditions such as chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson's disease, epilepsy, tremor, depression, and more. They find use across multiple settings including hospitals, clinics, and home healthcare environments.

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides neuromodulation market statistics, including the neuromodulation industry's global market size, regional shares, competitors with a neuromodulation market share, detailed neuromodulation market segments, market trends, and opportunities, and any further data you may need to thrive in the neuromodulation industry. This neuromodulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuromodulation market size has grown rapidly in recent years. It will grow from $6.43 billion in 2023 to $7.14 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. Historical growth in the field of neuromodulation can be largely attributed to several factors. These include the increasing prevalence of chronic disorders, the accumulation of clinical evidence and research supporting neuromodulation therapies, a growing demand from patients for non-invasive treatment options, government initiatives and funding supporting these advancements, the widening scope of indications for these therapies, as well as collaborations and partnerships within the industry that fostered innovation and development.

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $10.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. Anticipated growth in the upcoming period is linked to various factors, notably the miniaturization of devices, a heightened focus on neurological disorders prevalent in the aging population, increased applications in psychiatry, patient-centric approaches in treatment, and the global expansion of healthcare access.

The increasing prevalence of neurological disorders stands as a significant driver for the growth of the neuromodulation market. These disorders encompass a wide range of issues affecting the brain, nerves, and spinal cord. Neuromodulation interventions offer promising avenues for managing and regulating various neurological conditions, including Alzheimer's, Parkinson's, and epilepsy. Reports from the European Brain Council in April 2022 highlighted over 600 neurological diseases and nearly 300 psychiatric conditions globally, with 50 million individuals affected by Alzheimer's and other dementias. Epilepsy, affecting 65 million people worldwide, underscores the substantial impact of neurological disorders. Projections indicate a substantial rise in dementia cases in Europe, from 10.5 million to 18.7 million by 2050, signifying the pivotal role of neuromodulation in addressing these escalating health concerns.

The upward trajectory of healthcare expenditures is poised to drive the growth of the neuromodulation market. Healthcare expenditure encompasses spending on various health-related activities, including services, insurance, research, and public health initiatives. Increased healthcare spending facilitates the advancement and adoption of innovative therapies and diagnostic methods for neurological disorders. Enhanced financial resources also support extensive research into novel neuromodulation technologies, enhancing their effectiveness, safety, and precision. Notably, the Office for National Statistics reported a 9.4% nominal increase and a 9.7% real-term rise in healthcare spending in the UK between 2020 and 2021. Moreover, preventive care spending surged to $45.72 billion in 2021, more than doubling from the previous year, indicating a significant contribution to the growth of the neuromodulation market.

Technological advancements emerge as a pivotal trend shaping the neuromodulation market. Major players in this sector are dedicated to pioneering innovative technological solutions to fortify their market positions. For instance, Abbott's December 2022 launch of the Eterna spinal cord stimulation (SCS) system, featuring the smallest implantable, rechargeable spinal cord stimulator, illustrates the pursuit of advancements. Incorporating patented low-dose BurstDR stimulation, this system demonstrates superior pain relief compared to conventional approaches. Additionally, Abbott's NeuroSphere Virtual Clinic, launched in March 2021, represents a pioneering technology allowing remote patient-clinician interactions for optimizing treatment settings and exploring new therapeutic options. Approved by the US FDA, this initiative broadens access to effective treatment for chronic pain or Parkinson's disease, particularly beneficial during circumstances such as the COVID-19 pandemic.

Major players in the neuromodulation market are focusing on introducing next-generation devices with advanced features, such as the implantable pulse generator (IPG), to gain a competitive edge. For example, CVRx's November 2022 launch of the Barostim Neo2 IPG, an upgraded version of its neuromodulation device for heart failure treatment, exemplifies this pursuit. With improved efficiency, reduced size, and enhanced design facilitating easier implantation, the Barostim Neo2 retains the clinically proven Barostim therapy, emphasizing the drive towards patient-friendly, durable, and efficient solutions in neuromodulation.

In March 2022, Electromedical Products International Inc (EPI), a prominent US-based medical device manufacturer, completed the acquisition of Pulvinar Neuro LLC for an undisclosed sum. This strategic acquisition empowers EPI to further its progress in advancing patented technologies, notably transcranial alternating current stimulation (tACS), enhancing personalized feedback stimulation, and expanding its cloud-enabled digital therapeutics for psychiatric and neurological conditions. Pulvinar Neuro, a US-based neurotechnology company, specializes in leveraging cutting-edge technologies to support neuroscience research, aligning seamlessly with EPI's objectives in advancing medical innovation in this domain.

Major companies operating in the neuromodulation market report are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd., Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

North America was the largest region in the neuromodulation market in 2023. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the neuromodulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

1. Executive Summary

2. Neuromodulation Market Characteristics

3. Neuromodulation Market Trends And Strategies

4. Neuromodulation Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Neuromodulation Market Size and Growth

5.1. Global Neuromodulation Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Neuromodulation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Neuromodulation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neuromodulation Market Segmentation

6.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Internal Neuromodulation
External Neuromodulation (Non-invasive)
6.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Polymeric Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
6.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chronic Pain
Urinary And Fecal Incontinence
Migraine
Failed Back Syndrome
Parkinson Disease
Epilepsy
Tremor
Depression
Other Applications
6.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Home Healthcare

7. Neuromodulation Market Regional And Country Analysis

7.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neuromodulation Market

8.1. Asia-Pacific Neuromodulation Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neuromodulation Market

9.1. China Neuromodulation Market Overview
9.2. China Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neuromodulation Market

10.1. India Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neuromodulation Market

11.1. Japan Neuromodulation Market Overview
11.2. Japan Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neuromodulation Market

12.1. Australia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neuromodulation Market

13.1. Indonesia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neuromodulation Market

14.1. South Korea Neuromodulation Market Overview
14.2. South Korea Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neuromodulation Market

15.1. Western Europe Neuromodulation Market Overview
15.2. Western Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neuromodulation Market

16.1. UK Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neuromodulation Market

17.1. Germany Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neuromodulation Market

18.1. France Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neuromodulation Market

19.1. Italy Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neuromodulation Market

20.1. Spain Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neuromodulation Market

21.1. Eastern Europe Neuromodulation Market Overview
21.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neuromodulation Market

22.1. Russia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neuromodulation Market

23.1. North America Neuromodulation Market Overview
23.2. North America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neuromodulation Market

24.1. USA Neuromodulation Market Overview
24.2. USA Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neuromodulation Market

25.1. Canada Neuromodulation Market Overview
25.2. Canada Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neuromodulation Market

26.1. South America Neuromodulation Market Overview
26.2. South America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neuromodulation Market

27.1. Brazil Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neuromodulation Market

28.1. Middle East Neuromodulation Market Overview
28.2. Middle East Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neuromodulation Market

29.1. Africa Neuromodulation Market Overview
29.2. Africa Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neuromodulation Market Competitive Landscape And Company Profiles

30.1. Neuromodulation Market Competitive Landscape
30.2. Neuromodulation Market Company Profiles
- 30.2.1. Abbott Laboratories
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Soterix Medical Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Boston Scientific Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Medtronic plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Synapse Biomedical Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Neuromodulation Market Competitive Benchmarking

32. Global Neuromodulation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Neuromodulation Market

34. Neuromodulation Market Future Outlook and Potential Analysis

34.1 Neuromodulation Market In 2028 - Countries Offering Most New Opportunities
34.2 Neuromodulation Market In 2028 - Segments Offering Most New Opportunities
34.3 Neuromodulation Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies